The European Society of Cardiology Cardio-Oncology Guidelines: Evidence Base, Actionability, and Relevance to Clinical Practice

Darryl P Leong, Som D Mukherjee, Darryl P Leong, Som D Mukherjee

No abstract available

Keywords: epidemiology; guidelines; outcomes.

Conflict of interest statement

Dr Leong has received consultancy and speaker fees from Abbvie, Ferring Pharmaceuticals, Janssen, Myovant Sciences, Novartis, Pfizer, Sanofi, Tolmar, AstraZeneca, and Paladin related to prostate and myeloproliferative neoplasm cardio-oncology; and research support from Novartis. Dr Mukherjee has reported that he has no relationships relevant to the contents of this paper to disclose.

References

    1. Lyon A.R., López-Fernández T., Couch L.S., et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Eur Heart J. 2022;43(41):4229–4361. doi: 10.1093/eurheartj/ehac244.
    1. Ky B. JACC: CardioOncology: poised to serve a maturing, collaborative field. J Am Coll Cardiol CardioOnc. 2019;1:131–132.
    1. Cardinale D., Colombo A., Lamantia G., et al. Cardio-oncology: a new medical issue. Ecancermedicalscience. 2008;2:126. doi: 10.3332/ecancer.2008.126.
    1. Slamon D., Eiermann W., Robert N., et al. Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med. 2011;365:1273–1283.
    1. Thavendiranathan P., Negishi T., Somerset E., et al. Strain-guided management of potentially cardiotoxic cancer therapy. J Am Coll Cardiol. 2021;77:392–401.
    1. Cardinale D., Colombo A., Sandri M.T., et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation. 2006;114:2474–2481.
    1. Klimis H., Pinthus J.H., Aghel A., et al. The burden of uncontrolled cardiovascular risk factors in men with prostate cancer: a RADICAL-PC analysis. J Am Coll Cardiol CardioOnc. 2023;5(1):70–81.
    1. Wellbery C. The value of medical uncertainty? Lancet. 2010;375:1686–1687.

Source: PubMed

3
Předplatit